Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$3.92B |
| 2 |
Visa
V
|
+$551M |
| 3 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$406M |
| 4 |
UnitedHealth
UNH
|
+$395M |
| 5 |
Advanced Micro Devices
AMD
|
+$363M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.41B |
| 2 |
NVIDIA
NVDA
|
+$2.28B |
| 3 |
Microsoft
MSFT
|
+$2.02B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.83B |
| 5 |
Flutter Entertainment
FLUT
|
+$962M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Consumer Discretionary | 7.14% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 4.81% |
| 5 | Communication Services | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SA
3051
Seabridge Gold
SA
$2.84B
| $1.51M | ﹤0.01% |
132,045
+3,802
| +3% | +$58.6K |
|
3052
Cogent Biosciences
COGT
$6.64B
| $1.51M | ﹤0.01% |
193,068
+17,384
| +10% | +$173K |
|
3053
Core Laboratories
CLB
$491M
| $1.49M | ﹤0.01% |
86,300
+2,730
| +3% | +$52.7K |
|
|
MOFG
3054
DELISTED
MidWestOne Financial Group
MOFG
| $1.49M | ﹤0.01% |
51,198
+9,087
| +22% | +$278K |
|
3055
Amplitude
AMPL
$1.31B
| $1.49M | ﹤0.01% |
141,020
+12,483
| +10% | +$125K |
|
|
FARO
3056
DELISTED
Faro Technologies
FARO
| $1.49M | ﹤0.01% |
58,614
-2,511
| -4% | -$57.6K |
|
3057
Planet Labs
PL
$8.14B
| $1.49M | ﹤0.01% |
367,735
+41,588
| +13% | +$129K |
|
|
IAS
3058
DELISTED
Integral Ad Science
IAS
| $1.48M | ﹤0.01% |
142,137
+14,404
| +11% | +$158K |
|
3059
International Money Express
IMXI
$369M
| $1.48M | ﹤0.01% |
71,004
-2,256
| -3% | -$44.3K |
|
3060
Liberty Live Group Series A
LLYVA
$9.12B
| $1.48M | ﹤0.01% |
22,211
-2,321
| -9% | -$144K |
|
|
CTEV
3061
Claritev Corp
CTEV
$414M
| $1.48M | ﹤0.01% |
100,000
-180,000
| -64% | -$1.59M |
|
3062
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $1.48M | ﹤0.01% |
30,899
| – | – |
|
3063
Douglas Dynamics
PLOW
$972M
| $1.47M | ﹤0.01% |
62,227
+8,111
| +15% | +$205K |
|
|
DCH
3064
Dauch Corp
DCH
$1.38B
| $1.47M | ﹤0.01% |
251,899
+52,104
| +26% | +$326K |
|
|
BELFB
3065
Bel Fuse Inc Class B
BELFB
$3.91B
| $1.46M | ﹤0.01% |
17,750
+1,742
| +11% | +$141K |
|
3066
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $1.46M | ﹤0.01% |
18,761
+1
| +0% | +$78 |
|
3067
Prothena Corp
PRTA
$436M
| $1.46M | ﹤0.01% |
105,338
+10,116
| +11% | +$160K |
|
3068
Clover Health Investments
CLOV
$2.28B
| $1.45M | ﹤0.01% |
461,692
+355,926
| +337% | +$1.27M |
|
3069
Enliven Therapeutics
ELVN
$4.15B
| $1.45M | ﹤0.01% |
64,563
+8,346
| +15% | +$216K |
|
3070
PUT
Warby Parker
WRBY
$3.67B
| $1.45M | ﹤0.01% |
60,000
| – | – |
|
3071
LSI Industries
LYTS
$886M
| $1.45M | ﹤0.01% |
74,744
+4,920
| +7% | +$91.3K |
|
3072
PUT
Iridium Communications
IRDM
$5.12B
| $1.45M | ﹤0.01% |
+50,000
| New | +$1.49M |
|
3073
PubMatic
PUBM
$602M
| $1.45M | ﹤0.01% |
98,735
-30,461
| -24% | -$472K |
|
|
ORKA
3074
Oruka Therapeutics
ORKA
$5.72B
| $1.45M | ﹤0.01% |
+74,583
| New | +$1.82M |
|
|
PRA
3075
DELISTED
ProAssurance
PRA
| $1.45M | ﹤0.01% |
90,894
+5,777
| +7% | +$91.9K |
|
Similar funds
Barclays's Q4 2024 Portfolio in Review
As of Q4 2024, Barclays held 5,604 positions worth $357B, down 5.3% from $377B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays withdrew a net $28.7B in Q4 2024, closing 348 positions and reducing 1,552 holdings. Its most notable exit was Stericycle Inc, an estimated $97.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Barclays opened a new position in iShares Bitcoin Trust worth $131M.
- Barclays's largest Q4 2024 buy was iShares Bitcoin Trust: 2,473,064 shares worth $131M.
- Barclays added most to Honeywell in Q4 2024, an estimated $3.92B increase.
- Barclays's biggest Q4 2024 reduction was Apple, cutting an estimated $4.41B.
- Barclays fully exited Stericycle Inc in Q4 2024, selling an estimated $97.3M.
- Barclays's ten largest holdings make up 41% of its $357B portfolio in Q4 2024.
- Barclays opened 343 new positions and closed 348 in Q4 2024.
- Barclays's portfolio value fell 5.3% quarter-over-quarter to $357B.
Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.